PHAT — Phathom Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Phathom Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	287	183	155	381	297
Net Total Accounts Receivable
Net Total Receivables	—	—	—	1.64	38.8
Total Inventory
Prepaid Expenses
Total Current Assets	291	187	161	397	360
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.36	2.56	3.49	3.62	2.09
Other Long Term Assets
Total Assets	295	189	165	414	378
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	55.5	18.9	26.2	38.8	85.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	101	117	240	487	632
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	194	72.2	-74.8	-72.8	-254
Total Liabilities & Shareholders' Equity	295	189	165	414	378
Total Common Shares Outstanding